Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Current Drug Therapy

ACE inhibitors and ARBs: Managing potassium and renal function

Tasnim Momoniat, MBCHB, MRCP (UK), Duha Ilyas, MBBS, MRCP (UK) and Sunil Bhandari, MBCHB, FRCP, PhD, M CLIN EDU, FHEA
Cleveland Clinic Journal of Medicine September 2019, 86 (9) 601-607; DOI: https://doi.org/10.3949/ccjm.86a.18024
Tasnim Momoniat
Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duha Ilyas
Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil Bhandari
Department of Nephrology, Hull University, Teaching Hospitals NHS Trust, East Yorkshire, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 86 no. 9 601-607
DOI 
https://doi.org/10.3949/ccjm.86a.18024
PubMed 
31498767

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online September 1, 2019.

Copyright & Usage 
© 2019 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Tasnim Momoniat, MBCHB, MRCP (UK)
  1. Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, UK
  1. Duha Ilyas, MBBS, MRCP (UK)
  1. Department of Nephrology, Hull University Teaching Hospitals NHS Trust, East Yorkshire, UK
  1. Sunil Bhandari, MBCHB, FRCP, PhD, M CLIN EDU, FHEA⇑
  1. Department of Nephrology, Hull University, Teaching Hospitals NHS Trust, East Yorkshire, UK
  1. ADDRESS: Professor Sunil Bhandari, Department of Nephrology, Hull Royal Infirmary, Hull University Teaching Hospitals NHS Trust, Anlaby Road, Hull, East Yorkshire HU3 2JZ, United Kingdom; Sunil.Bhandari{at}hey.nhs.uk
View Abstract

Cited By...

  • 49 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 86 (9)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 9
1 Sep 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ACE inhibitors and ARBs: Managing potassium and renal function
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ACE inhibitors and ARBs: Managing potassium and renal function
Tasnim Momoniat, Duha Ilyas, Sunil Bhandari
Cleveland Clinic Journal of Medicine Sep 2019, 86 (9) 601-607; DOI: 10.3949/ccjm.86a.18024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ACE inhibitors and ARBs: Managing potassium and renal function
Tasnim Momoniat, Duha Ilyas, Sunil Bhandari
Cleveland Clinic Journal of Medicine Sep 2019, 86 (9) 601-607; DOI: 10.3949/ccjm.86a.18024
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • ACE INHIBITORS AND ARBs
    • RISK FACTORS FOR HYPERKALEMIA
    • ACE INHIBITORS, ARBs, AND RENAL FUNCTION
    • NEED FOR MONITORING
    • WHAT DO THE GUIDELINES SUGGEST?
    • OUR RECOMMENDATIONS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • The Effects of Medication Strategies on Cardiovascular Outcomes in Patients with Marfan Syndrome: A Consistency Model Analysis
  • In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
  • Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
  • ACE inhibitor and ARB therapy: Practical recommendations
  • Google Scholar

More in this TOC Section

  • Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
  • Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
  • A practical guide for buprenorphine initiation in the primary care setting
Show more Current Drug Therapy

Similar Articles

Subjects

  • Cardiology
  • Drug Therapy
  • Nephrology
  • Preventive Care

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire